Objective: to investigate the cognitive skills of patients with relapsing remitting multiple sclerosis (RRMS), secondary progressive MS (SPMS), and primary progressive MS (PPMS) relative to healthy control subjects and to assess whether there is heterogeneity in the type of cognitive disabilities demonstrated by patients with different MS phenotypes.Methods: RRMS patients (n = 108), SPMS patients (n = 71), PPMS patients (n = 55), and healthy control subjects (n = 67) underwent neuropsychological assessment with the Brief Repeatable Battery of Neuropsychological Tests.Results: relative to controls, cognitive performance of RRMS patients was deficient when tasks required higher-order working memory (WM) processes (Word List Generation, 10/36 ...
Multiple Sclerosis (MS) is a chronic inflammatory/demyelinating and neurodegenerative disease of the...
Multiple Sclerosis (MS) is a chronic inflammatory/demyelinating and neurodegenerative disease of the...
Cognitive impairment is commonly described in multiple sclerosis (MS), but conflicting results have ...
Objective: To investigate the cognitive skills of patients with relapsing remitting multiple scleros...
This paper presents results of two studies conducted to investigate cognition in different MS subtyp...
International audienceBackground: Cognitive deficits are common in multiple sclerosis (MS) and affec...
The purpose of the study was to identify changes in cognitive abilities that affect patients with re...
Cognitive impairment (CI) is present in all stages and subtypes of multiple sclerosis (MS). However,...
AIMS: Multiple sclerosis (MS) is a neurologic disease characterized by the occurrence of wideapread ...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
There is limited and inconsistent information on the clinical determinants of cognitive impairment (...
BackgroundCognitive impairment is frequent and disabling in multiple sclerosis (MS). Changes in info...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Multiple Sclerosis (MS) is a chronic inflammatory/demyelinating and neurodegenerative disease of the...
Multiple Sclerosis (MS) is a chronic inflammatory/demyelinating and neurodegenerative disease of the...
Cognitive impairment is commonly described in multiple sclerosis (MS), but conflicting results have ...
Objective: To investigate the cognitive skills of patients with relapsing remitting multiple scleros...
This paper presents results of two studies conducted to investigate cognition in different MS subtyp...
International audienceBackground: Cognitive deficits are common in multiple sclerosis (MS) and affec...
The purpose of the study was to identify changes in cognitive abilities that affect patients with re...
Cognitive impairment (CI) is present in all stages and subtypes of multiple sclerosis (MS). However,...
AIMS: Multiple sclerosis (MS) is a neurologic disease characterized by the occurrence of wideapread ...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
There is limited and inconsistent information on the clinical determinants of cognitive impairment (...
BackgroundCognitive impairment is frequent and disabling in multiple sclerosis (MS). Changes in info...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Multiple Sclerosis (MS) is a chronic inflammatory/demyelinating and neurodegenerative disease of the...
Multiple Sclerosis (MS) is a chronic inflammatory/demyelinating and neurodegenerative disease of the...
Cognitive impairment is commonly described in multiple sclerosis (MS), but conflicting results have ...